Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    ABBV-838
Show Display Options
Rank Status Study
1 Active, not recruiting Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: ABBV-838;   Drug: Pomalidomide;   Drug: Dexamethasone
2 Recruiting A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
Condition: Multiple Myeloma
Interventions: Drug: Venetoclax;   Drug: ABBV-838;   Drug: Dexamethasone

Study has passed its completion date and status has not been verified in more than two years.